Welcome to our dedicated page for Oklo SEC filings (Ticker: oklo), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Oklo’s liquid-metal fast reactor ambitions make its disclosures rich with technical details on licensing, fuel recycling, and long-term power-purchase economics—dense enough to overwhelm even seasoned analysts. If you have ever wondered why cash-flow forecasts shift after a new NRC milestone or where insider grants are buried, you are not alone. Investors typing “Oklo SEC filings explained simply” reach this page because Stock Titan’s AI has already mapped the answers.
Our platform reads every Oklo annual report 10-K simplified for reactor development costs, scans each Oklo quarterly earnings report 10-Q filing for R&D burn, and flags Oklo 8-K material events explained the instant they hit EDGAR. Need to follow Oklo insider trading Form 4 transactions? Real-time alerts show Oklo Form 4 insider transactions real-time—so monitoring Oklo executive stock transactions Form 4 never requires manual digging. Our AI summarizes complex tables, links narrative sections, and highlights risk-factor changes, delivering concise Oklo earnings report filing analysis you can act on.
Use cases investors rely on every day:
- Track reactor-licensing progress without poring over technical exhibits
- Compare segment spending across statements in seconds
- Spot compensation shifts through the Oklo proxy statement executive compensation filings
Whether you are understanding Oklo SEC documents with AI for the first time or auditing years of data, Stock Titan delivers expert analysis, comprehensive coverage of all forms, and instant updates—turning hundreds of pages into decisive insight.
Oklo Inc. insider sale by Chief Legal & Strategy Officer and director: The Form 4 shows William Carroll Murphy Goodwin (reporting person) sold 41,387 shares of Class A common stock on 09/05/2025 in multiple transactions at a weighted-average price of $70.0921 per share, with prices in the range $70.00–$70.25. Following the reported transactions the filing indicates 0 shares beneficially owned by the reporting person. The sale was reported on the form by an attorney-in-fact and signed on 09/09/2025. The filer identified as an officer (Chief Legal & Strategy Officer) and director of the issuer.
Oklo Inc. is offering up to $539,999,000 of Class A common stock through an amended at-the-market Sales Agreement with Goldman Sachs, BofA Securities, B. Riley and TD Securities, leaving approximately $139,999,000 of capacity remaining under the agreement. The Sales Agents may sell shares across markets and will receive commissions up to 2.5% of gross sales. The prospectus discloses historical net tangible book value of $660.4 million, or $4.47 per share, and an as-adjusted value of $1,119.4 million, or $7.74 per share, implying immediate dilution to new investors of $65.90 per share at an assumed $73.64 price. Material company milestones stated include a DOE site use permit and fuel award at Idaho National Laboratory, a Memorandum of Agreement with DOE (Sept 25, 2024), completion of an NRC Phase I pre-application readiness assessment (July 2025) with no significant gaps identified, a December 2024 12 GWe Master Power Agreement with Switch, an approximate 14,100 MWe order book, and a targeted first Aurora powerhouse deployment in late 2027 or early 2028.
Oklo Inc. insider Form 4: William Carroll Murphy Goodwin, the company's Chief Legal & Strategy Officer, had 82,743 restricted stock units (RSUs) released on 08/14/2025, each representing one share of Class A common stock. On the same date the filing shows a disposition of 41,356 shares sold at $76.802 per share, leaving 41,387 shares beneficially owned following the transactions. The RSUs vested one-third on August 12, 2025 and the balance vests in eight substantially equal quarterly installments. The Form 4 is signed by an attorney-in-fact on behalf of the reporting person.
Oklo Inc. Chief Legal & Strategy Officer and director William Carroll Murphy Goodwin reported initial beneficial ownership via a Form 3 for OKLO, reflecting restricted stock units that convert to Class A common stock. The filing records 248,227 RSUs vesting one-third on August 12, 2025 and thereafter in eight quarterly installments; 10,000 RSUs vesting in full on November 29, 2025; and 2,202 RSUs vesting in three annual installments beginning November 29, 2025. The event date is 08/06/2025.
Patrick Joseph Schweiger, serving as Chief Technology Officer of Oklo Inc., filed an initial Form 3 reporting ownership of 38,648 restricted stock units that each represent a contingent right to one share of the issuer's Class A Common Stock. The RSUs vest in 36 substantially equal monthly installments beginning on March 15, 2026. The filing was submitted as an individual statement and is accompanied by a power of attorney exhibit.
Oklo Inc. is advancing its Aurora fast‑reactor program and expanded into radioisotopes by acquiring Atomic Alchemy for $28,424 thousand (stock consideration $27,408 thousand and $900 thousand cash). The acquisition preliminarily allocated $27,500 thousand to indefinite‑lived IPR&D (two projects, Abundantia $4,600k and Meitner $22,900k) and $6,720 thousand to goodwill.
On the balance sheet as of June 30, 2025, Oklo held total cash, cash equivalents and marketable debt securities of $682,965 thousand (cash $226,771k; marketable debt securities fair value $456,194k). For the six months ended June 30, 2025 the company reported a net loss of $34,495 thousand, loss from operations of $45,889 thousand, net cash used in operating activities of $30,714 thousand, and an accumulated deficit of $169,604 thousand. In June 2025 Oklo completed a public offering of 7,666,667 shares at $60.00 per share, raising gross proceeds of $460,000 thousand and net proceeds of $441,600 thousand. Management states existing liquidity is expected to fund operations for at least one year following these condensed financial statements.